Radius Health Inc logo

RDUS - Radius Health Inc News Story

$10.95 0.0  0.4%

Last Trade - 25/09/20

Mid Cap
Market Cap £399.3m
Enterprise Value £468.7m
Revenue £157.3m
Position in Universe 2886th / 6417

BUZZ-Radius Health: Down after EMA panel's negative view on osteoporosis drug

Thu 22nd March, 2018 2:02pm
** Drug developer's shares  RDUS.O  down ~7 pct at $32.67 in
morning trade
    ** European Medicines Agency (EMA) panel gives negative
trend vote for abaloparatide-SC, Radius Health's treatment for
osteoporosis in postmenopausal women 
    ** Panel says it sees lower benefit from the treatment 
    ** Radius to appeal and seek re-examination 
    **  Abaloparatide injection, known in the U.S. as Tymlos,
was approved by FDA in April
    ** Will continue to make our efforts to make
abaloparatide-SC available in Japan through our collaboration
with Teijin, as well as in other markets through partnership
agreements -- Radius CEO
    ** Stock has risen ~6 pct YTD

 (Reporting by Mrinalini Krothapalli)
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.